How Identity And Brain Mapping Are Changing The Way Companies Advertise
For your business to be successful, people have to know it exists. You may be able to get the company off the ground through word of mouth, but eventually your business will need some well-targeted advertising and marketing.
As the advertising landscape continues to change, it can be difficult for business owners to figure out where to put their ad dollars. Pranav Yadav, CEO of Neuro-Insight, and George Slefo, Tech Reporter at AdAge, discuss the present and future of the advertising industry.
Yadav's company uses neuromarketing to help companies create targeted advertisements that spike brain activity and memory. Yadav explains exactly how they use brain mapping to improve the efficacy of ads.
Slefo takes a look at where the money is going in the advertising industry. According to the International Advertising Bureau, 75 cents of every ad dollar goes to Facebook and Google. Slefo says it's because they have proven time and again to give companies strong returns on investment.
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
